title: EORTC Group Study 30851: a phase II study of neoadjuvant chemotherapy in patients with invasive bladder cancer.
authors.affiliation: University Hospital Dijkzigt, Department of Medical Oncology, The Netherlands.
authors.forename: T A
authors.initials: TA
authors.lastname: Splinter
authors.forename: D
authors.initials: D
authors.lastname: Jacqmin
authors.forename: J T
authors.initials: JT
authors.lastname: Roberts
authors.forename: M
authors.initials: M
authors.lastname: Pavone-Macaluso
authors.forename: M
authors.initials: M
authors.lastname: de Pauw
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: P
authors.initials: P
authors.lastname: Carpentier
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology